HCV Test and Treat Utilizing Simplified HCV Patient Education

PHASE4TerminatedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

November 11, 2022

Primary Completion Date

November 22, 2024

Study Completion Date

November 22, 2024

Conditions
Hepatitis C
Interventions
DIAGNOSTIC_TEST

Cepheid POC HCV Viremia (RNA) test

The Cepheid Xpert HCV Viral Load (VL) Fingerstick assay is a test designed for the quantitation (amount) of Hepatitis C Virus (HCV) DNA in human whole blood. The HCV RNA result will be compared to standardized laboratory assessment for HCV Viremia. The Cepheid test is for being conducted for research use only and will not be used for HCV diagnosis or treatment decisions.

OTHER

HCV education from a health care provider

HCV education provided by health care provider. HCV Education will include HCV disease overview, HCV screening, treatment with G/P, and post treatment assessment and management

DRUG

Glecaprevir and Pibrentasvir

G/P will be provided for 8 weeks.

Trial Locations (3)

10019

ColumbiaDoctors Midtown, New York

10036

Weill Cornell Medicine Midtown Center for Treatment and Research, New York

11101

Phoenix House, Long Island City

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

AbbVie

INDUSTRY

lead

Weill Medical College of Cornell University

OTHER